FY2019 EPS Estimates for U.S. Physical Therapy, Inc. Increased by Analyst (NYSE:USPH)

U.S. Physical Therapy, Inc. (NYSE:USPH) – Research analysts at Jefferies Financial Group lifted their FY2019 EPS estimates for shares of U.S. Physical Therapy in a report released on Monday, August 12th. Jefferies Financial Group analyst B. Tanquilut now expects that the company will post earnings of $2.94 per share for the year, up from their prior forecast of $2.92. Jefferies Financial Group also issued estimates for U.S. Physical Therapy’s Q4 2019 earnings at $0.75 EPS and FY2020 earnings at $3.13 EPS.

U.S. Physical Therapy (NYSE:USPH) last posted its quarterly earnings data on Thursday, August 8th. The company reported $0.81 earnings per share for the quarter, hitting the Thomson Reuters’ consensus estimate of $0.81. The company had revenue of $126.40 million for the quarter, compared to analysts’ expectations of $124.86 million. U.S. Physical Therapy had a net margin of 6.22% and a return on equity of 19.50%. U.S. Physical Therapy’s revenue for the quarter was up 9.8% compared to the same quarter last year. During the same period in the prior year, the business earned $0.73 earnings per share.

USPH has been the topic of a number of other reports. Zacks Investment Research upgraded shares of U.S. Physical Therapy from a “hold” rating to a “buy” rating and set a $127.00 price target on the stock in a research report on Friday, April 26th. Barrington Research reiterated a “hold” rating on shares of U.S. Physical Therapy in a research report on Friday, May 3rd. Two investment analysts have rated the stock with a hold rating and three have issued a buy rating to the company. The company currently has a consensus rating of “Buy” and a consensus price target of $113.54.

USPH stock opened at $133.59 on Wednesday. The company has a current ratio of 1.18, a quick ratio of 1.18 and a debt-to-equity ratio of 0.39. The company’s 50 day moving average is $126.98 and its 200 day moving average is $115.85. The stock has a market cap of $1.70 billion, a price-to-earnings ratio of 50.41, a price-to-earnings-growth ratio of 4.03 and a beta of 1.13. U.S. Physical Therapy has a 1-year low of $98.69 and a 1-year high of $137.15.

Hedge funds have recently made changes to their positions in the stock. TCG Advisors LP purchased a new stake in U.S. Physical Therapy in the first quarter worth $25,000. NumerixS Investment Technologies Inc purchased a new stake in U.S. Physical Therapy in the second quarter worth $61,000. Quadrant Capital Group LLC lifted its stake in U.S. Physical Therapy by 1,729.4% in the first quarter. Quadrant Capital Group LLC now owns 622 shares of the company’s stock worth $63,000 after acquiring an additional 588 shares during the period. Tower Research Capital LLC TRC purchased a new stake in U.S. Physical Therapy in the second quarter worth $91,000. Finally, Resources Investment Advisors LLC. lifted its position in U.S. Physical Therapy by 96.6% during the second quarter. Resources Investment Advisors LLC. now owns 816 shares of the company’s stock valued at $100,000 after buying an additional 401 shares during the period. 99.58% of the stock is owned by institutional investors.

In related news, COO Glenn Mcdowell sold 5,000 shares of the firm’s stock in a transaction on Wednesday, August 14th. The stock was sold at an average price of $134.55, for a total value of $672,750.00. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Also, CEO Christopher J. Reading sold 19,860 shares of the firm’s stock in a transaction on Tuesday, May 21st. The stock was sold at an average price of $119.36, for a total value of $2,370,489.60. The disclosure for this sale can be found here. In the last three months, insiders have sold 32,062 shares of company stock valued at $4,006,520. Insiders own 2.50% of the company’s stock.

The business also recently disclosed a quarterly dividend, which will be paid on Friday, September 13th. Stockholders of record on Thursday, August 15th will be paid a dividend of $0.30 per share. This represents a $1.20 dividend on an annualized basis and a dividend yield of 0.90%. The ex-dividend date of this dividend is Wednesday, August 14th. This is a positive change from U.S. Physical Therapy’s previous quarterly dividend of $0.27. U.S. Physical Therapy’s dividend payout ratio is 40.75%.

U.S. Physical Therapy Company Profile

U.S. Physical Therapy, Inc, through its subsidiaries, operates outpatient physical therapy clinics that provide pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.

See Also: Trading Ex-Dividend

Earnings History and Estimates for U.S. Physical Therapy (NYSE:USPH)

Receive News & Ratings for U.S. Physical Therapy Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for U.S. Physical Therapy and related companies with MarketBeat.com's FREE daily email newsletter.